FDA Brief

Warning letters Drugs

FDA warning letter to

IBSPOT.com Inc.

High riskIssued Oct 27, 2025Posted Nov 11, 2025Center for Drug Evaluation and Research (CDER)

FDA says IBSPOT.com sold unapproved motion sickness patches containing diphenhydramine and diclofenac that the labels never listed.

What happened

FDA bought "Taoscare Motion Sickness Patch" and "Navabelle Motion Sickness Patches" through the company's website, www.ibspot.com, and had them tested in a laboratory. The tests found diphenhydramine, diphenhydramine N-oxide and diclofenac in the patches, none of which appear on the product labels. FDA cited the products as unapproved new drugs (drugs sold without FDA approval) and as misbranded (labeling that is false or misleading).

What FDA found

  1. The patches are drugs sold without an FDA-approved application, which the law requires for new drugs.

    Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  2. The labels are false or misleading because they do not disclose that the patches contain diphenhydramine, diphenhydramine N-oxide or diclofenac, so consumers cannot check for allergies or drug interactions.

    Section 502(a) of the FD&C Act, 21 U.S.C. 352(a)
  3. Shipping these unapproved drugs across state lines is a prohibited act.

    Section 301(d) of the FD&C Act, 21 U.S.C. 331(d)
  4. Shipping these misbranded drugs across state lines is a prohibited act.

    Section 301(a) of the FD&C Act, 21 U.S.C. 331(a)

What FDA wants

FDA asks the company to write within fifteen working days describing the specific steps taken to correct the violations and prevent them from happening again, with supporting documents, or to explain why it believes the products are not in violation. The reply goes by email to CDER's Office of Unapproved Drugs and Labeling Compliance at FDAAdvisory@fda.hhs.gov, with the firm name and identifier "715657" in the subject line.

Who should pay attention

  • online marketplaces and web sellers listing third-party motion sickness patches
  • brands selling anti-nausea or motion sickness patches
  • importers and distributors of consumer drug products from overseas suppliers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk